Aberrant S1P signal transduction and intracellular transit in B cell lymphomas may potentially result in the deregulation of CD1d-mediated activation NKT cells by lymphomas, contributing to the NKT-cell activation deficit described here. Here, CD1D is linked to lymphoma.